Enabling non invasive treatment of musculoskeletal pathologies in a new remote healthcare world

在新的远程医疗保健世界中实现肌肉骨骼疾病的无创治疗

• 批准号: 80837
• 金额: $ 33.96万
• 依托单位: VITRUE LTD
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2020
• 资助国家: 英国
• 起止时间: 2020 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=80837
• 关键词: Enabling; non; invasive; treatment; musculoskeletal

This project will combine and build upon cutting edge technical and clinical innovations from a fast growth musculoskeletal health diagnostics startup company and a world leading innovator in non invasive musculoskeletal interventions. The COVID-19 pandemic has caused immense disruption across industries, none more so than in healthcare. The effects of this change will last long after the outbreak is brought under control. In order to provide healthcare services that meet and exceed the standards of care we were used to before COVID-19 massive leaps in innovation will be required. This project will help develop new and innovative methods to deliver AposTherapy's world leading non-invasive treatments through cutting edge research in musculoskeletal treatment, computer vision and biomechanics analysis.

该项目将联合收割机结合并建立在一家快速增长的肌肉骨骼健康诊断初创公司和一家世界领先的非侵入性肌肉骨骼干预创新者的尖端技术和临床创新之上。COVID-19大流行对各行各业造成了巨大的破坏，其中尤以医疗保健为甚。这一变化的影响将在疫情得到控制后很长一段时间内持续下去。为了提供符合并超过我们在COVID-19之前习惯的护理标准的医疗保健服务，需要在创新方面实现巨大飞跃。该项目将通过肌肉骨骼治疗、计算机视觉和生物力学分析的前沿研究，帮助开发新的创新方法，提供AposTherapy世界领先的非侵入性治疗。